BamSEC and AlphaSense Join Forces
Learn More

MultiCell Technologies, Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 10-Q 16 pages License Agreement
12/34/56
EX-10.1
from 10-Q 26 pages Research Agreement
12/34/56
EX-10.15
from 10-K 5 pages Amendment No. 4 to Foreclosure Sale Agreement
12/34/56
EX-10.15
from 10-K 1 page Addendum 2 to Convertible Debenture and Equity Investment Agreement
12/34/56
EX-10.13
from 10-K 14 pages Sponsored Research Agreement
12/34/56
EX-10.1
from 8-K 1 page Material contract
12/34/56
EX-10.1
from 10-Q 4 pages Amendment No. 3 to Foreclosure Sale Agreement
12/34/56
EX-10.1
from 8-K 3 pages Amendment No. 2 to Foreclosure Sale Agreement
12/34/56
EX-10.1
from 8-K 4 pages Agreement
12/34/56
EX-10.1
from 8-K 1 page Material contract
12/34/56
EX-10.1
from 8-K 1 page Material contract
12/34/56
EX-10.1
from 8-K 22 pages MultiCell Technologies, Inc. 2004 Equity Incentive Plan
12/34/56
EX-10.1
from 8-K 1 page Material contract
12/34/56
EX-10.3
from 8-K 14 pages Series B Convertible Preferred Stock Purchase Agreement
12/34/56
EX-10.2
from 8-K 95 pages Foreclosure Sale Agreement
12/34/56
EX-10.1
from 8-K 18 pages Exclusive License Agreement Between Xenogenics Corporation and Rutgers, the State University of New Jersey
12/34/56
EX-10.1
from 8-K 22 pages MultiCell Technologies, Inc. 2004 Equity Incentive Plan
12/34/56
EX-10.1
from 8-K 10 pages Confidential Treatment Has Been Requested With Respect to Certain Portions of This Exhibit Pursuant to a Request for Confidential Treatment Under Rule 24b-2 Promulgated Under the Securities Exchange Act of 1934, as Amended. Omitted Portions Have Been Filed Separately With the Securities and Exchange Commission. Cooperative Research and Product Development Agreement
12/34/56
EX-10.1
from 8-K 20 pages License and Technology Purchase Agreement Between Corning and MultiCell Relating to Hepatocytes
12/34/56
EX-10.1
from 8-K 10 pages License Agreement
12/34/56